PMID: 8949425Sep 1, 1996Paper

Cutaneous manifestations of systemic lupus erythematosus

The British Journal of Dermatology
J A YellS M Burge

Abstract

We have assessed the cutaneous signs in 73 patients with systemic lupus erythematosus (SLE), seen during a 5-year period in an English hospital. Most previous information about the cutaneous manifestations of SLE has been obtained from studies performed in the U.S.A. We classified lesions as specific cutaneous and mucosal LE (acute, subacute and chronic) or non-specific LE-related, e.g. photosensitivity, urticaria, erythema, Raynaud's phenomenon or vasculitis. Acute cutaneous LE lesions included a butterfly rash with erythematous macules, telangiectasia or papulosquamous lesions, seen in 37 patients (51%) and facial oedema seen in four patients (5%). Five patients (7%) had psoriasiform subacute cutaneous LE. Chronic cutaneous LE was common: 18 patients (25%) had chronic discoid lesions (DLE) and, in 12 (15%), these had preceded systemic disease. One patient had facial lupus profundus. Ten patients (14%) had scarring alopecia secondary to DLE. Fifteen patients (20.5%) had chronic chilblain lupus. Twenty-three patients (31.5%) had a history of mouth ulceration. Of these, 11 (15%) gave a history of ulcers at the onset of their disease. Three (4%) had erythema and superficial ulceration of the palate, not typical of aphthous ulcers...Continue Reading

References

Aug 1, 1979·Arthritis and Rheumatism·J DimantM Weiner
Apr 1, 1978·Annals of the Rheumatic Diseases·R GrigorG R Hughes
May 1, 1978·The British Journal of Dermatology·L G Millard, N R Rowell
Aug 1, 1992·Clinical Otolaryngology and Allied Sciences·A K RobsonP R Millard
Aug 1, 1991·Seminars in Arthritis and Rheumatism·M PistinerJ R Klinenberg
Oct 1, 1987·Australian and New Zealand Journal of Medicine·C WeinsteinR Buchanan
Jul 1, 1985·Annals of Internal Medicine·B R ReedD A Norris
Apr 1, 1974·The American Journal of the Medical Sciences·D Alarcon-Segovia, J A Cetina
Jan 1, 1968·Medicine·J Brown, R K Winkelmann
Nov 1, 1982·Arthritis and Rheumatism·E M TanR J Winchester
Apr 1, 1981·Journal of the American Academy of Dermatology·J N Gilliam, R D Sontheimer
Jul 1, 1994·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M HideM W Greaves
Sep 1, 1958·The American Journal of Medicine·R ARMAS-CRUZF GONZALEZ
Nov 1, 1963·Archives of Internal Medicine·D ALARCON-SEGOVIAJ F FAIRBAIRN
Oct 12, 1964·JAMA : the Journal of the American Medical Association·E L DUBOIS, D L TUFFANELLI
May 1, 1965·Annals of Internal Medicine·D ALARCON SEGOVIA, P J OSMUNDSON

❮ Previous
Next ❯

Citations

Apr 7, 2004·Current Treatment Options in Cardiovascular Medicine·Elias ToubiTheo Dov Golan
Jun 2, 2005·La Revue de médecine interne·F BallangerM Hamidou
Feb 1, 2008·Nature Clinical Practice. Rheumatology·Michelle M A Fernando, David A Isenberg
Jun 26, 2001·The British Journal of Dermatology·C H OrteuR H Bull
Jul 9, 2002·The British Journal of Dermatology·K MoriharaH Yasuno
Apr 20, 1999·International Journal of Dermatology·M B Maessen-VischH A Neumann
Jul 18, 2002·The Australasian Journal of Dermatology·Steven Kossard
Apr 18, 2001·Journal of the European Academy of Dermatology and Venereology : JEADV·E VocksJ Ring
Oct 24, 2009·Current Opinion in Rheumatology·Jennie T Clarke, Victoria P Werth
Jun 20, 2003·American Journal of Clinical Dermatology·Paolo FabbriMarzia Caproni
Nov 28, 2007·American Journal of Clinical Dermatology·Rocco SerraoJoseph C English
Oct 15, 2009·American Journal of Clinical Dermatology·Hobart W Walling, Richard D Sontheimer
Mar 13, 2014·Indian Dermatology Online Journal·Carina M Grönhagen, Filippa Nyberg
May 9, 2014·The Journal of Allergy and Clinical Immunology. in Practice·Cem Akin
Feb 13, 2001·Journal of Cutaneous Pathology·A N Crowson, C Magro
Jan 1, 2009·BMJ Case Reports·Pasquale MansuetoGaetana Di Fede
Jul 2, 2005·Autoimmunity Reviews·Victoria P Werth
May 18, 2005·Clinics in Dermatology·Andreas Katsambas, Christina Stefanaki
Nov 8, 2015·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·Pavel KolkhirMarcus Maurer
Oct 23, 2008·Oral and Maxillofacial Surgery Clinics of North America·David B Powers
Apr 20, 2001·Seminars in Cutaneous Medicine and Surgery·D P McCauliffe
Apr 19, 2003·Journal of the European Academy of Dermatology and Venereology : JEADV·B MarinovićD Loncarić
Sep 14, 2007·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Jeaneth López-LabadyMagdalena Mata de Henning
Jan 24, 2007·The Journal of Dermatology·Ulker GülGülşah Kaygusuz
Dec 23, 2011·Arthritis Care & Research·Yesenia Santiago-CasasElizabeth E Brown
May 28, 2010·Journal of Cutaneous Pathology·Alireza SepehrSteven R Tahan
Mar 24, 2016·Journal of Foot and Ankle Research·Simon J OtterKeith Rome
Apr 18, 2006·Seminars in Cutaneous Medicine and Surgery·Leonard C Sperling, Shawn E Cowper
Jun 21, 2005·Journal of the American Academy of Dermatology·Elizabeth K RossJerry Shapiro
Mar 8, 2003·Dermatologic Clinics·Edwin T Parks, Henry Lancaster
Nov 20, 2012·Dermatologic Clinics·Siamak Moghadam-Kia, Andrew G Franks
Jul 12, 2011·Journal of the American Academy of Dermatology·Kristen FoeringVictoria P Werth
Feb 5, 2015·Journal of the American Academy of Dermatology·Lisa M ArkinAmy S Paller

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.